Skeletal Muscle Lipid Accumulation in Type 2 Diabetes May Involve the Liver X Receptor Pathway
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Liver X receptors (LXRs) are important regulators of cholesterol and lipid metabolism and are also involved in glucose metabolism. However, the functional role of LXRs in human skeletal muscle is at present unknown. This study demonstrates that chronic ligand activation of LXRs by a synthetic LXR agonist increases the uptake, distribution into complex cellular lipids, and oxidation of palmitate as well as the uptake and oxidation of glucose in cultured human skeletal muscle cells. Furthermore, the effect of the LXR agonist was additive to acute effects of insulin on palmitate uptake and metabolism. Consistently, activation of LXRs induced the expression of relevant genes: fatty acid translocase (CD36/FAT), glucose transporters (GLUT1 and -4), sterol regulatory element–binding protein-1c, peroxisome proliferator–activated receptor-γ, carnitine palmitoyltransferase-1, and uncoupling protein 2 and 3. Interestingly, in response to activation of LXRs, myotubes from patients with type 2 diabetes showed an elevated uptake and incorporation of palmitate into complex lipids but an absence of palmitate oxidation to CO2. These results provide evidence for a functional role of LXRs in both lipid and glucose metabolism and energy uncoupling in human myotubes. Furthermore, these data suggest that increased intramyocellular lipid content in type 2 diabetic patients may involve an altered response to activation of components in the LXR pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491 · cited 1×
“Moreover, we observed a similar increase in CPT-1 expression for control as well as type 2 diabetic myotubes, which mainly regulates mitochondrial fatty acid oxidation (32).”
BackgroundSeo, J. B., Moon, H. M., Kim, W. S., Lee, Y. S., Jeong, H. W., Yoo, E. J., Ham, J., Kang, H., Park, M.-G., Steffensen, K. R., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3430-3444.2004 · Cited by 250 · cited 2×
“LXR agonist treatment has also been reported to increase lipid accumulation in differentiating adipocytes, and fat deposits in LXR- /- – deficient mice have been shown to be smaller than in age-matched wild-type littermates (1,24).”
BackgroundMontell, E., Turini, M., Marotta, M., Roberts, M., Noé, V., Ciudad, C. J., Macé, K., & Gómez-Foix, A. M. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e229 · Cited by 245
Reduced Lipid Oxidation in Skeletal Muscle From Type 2 Diabetic Subjects May Be of Genetic Origin
Gaster, M., Rustan, A. C., Aas, V., & Beck-Nielsen, H. (2004) · Diabetes · doi:10.2337/diabetes.53.3.542 · Cited by 176 · cited 5×
“assayed for protein (16), and cellular lipids were extracted (17).”
BackgroundMethodInfluentialSelf-citationGoodpaster, B. H., & Kelley, D. E. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0086-2 · Cited by 155
Blaak, E. E., Wagenmakers, A. J. M., Glatz, J. F. C., Wolffenbuttel, B. H. R., Kemerink, G. J., Langenberg, C. J. M., Heidendal, G. A. K., & Saris, W. H. M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.1.e146 · Cited by 140 · cited 1×
“Moreover, it has been observed that lipid oxidation is reduced in muscle fibers from obese and type 2 diabetic subjects (41,42) and that complete palmitate oxidation (CO2 production) is decreased in type 2 diabetic myotubes (17).”
BackgroundGaster, M., & Beck-Nielsen, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.05.006 · Cited by 38 · cited 2×
“Cell-free flasks (no-cell controls) were included to correct for unspecific CO2 trapping (19).”
MethodSelf-citation
Cited by
The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A., & Gilbert, E. R. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-10 · Cited by 450
Skeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
Self-citationChallenges and Perspectives in the Treatment of Diabetes Associated Breast Cancer
Samuel, S. M., Varghese, E., Varghese, S., & Büsselberg, D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.004 · Cited by 141
Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M. (2009) · Diabetes · doi:10.2337/db08-1043 · Cited by 73
Metabolic switching of human myotubes is improved by n-3 fatty acids
Hessvik, N. P., Bakke, S. S., Fredriksson, K., Boekschoten, M. V., Fj⊘rkenstad, A., Koster, G., Hesselink, M. K., Kersten, S., Kase, E. T., Rustan, A. C., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003319 · Cited by 71
Self-citation
Metadata
- Authors
- Kase, E. T., Wensaas, A. J., Aas, V., Højlund, K., Levin, K., Thoresen, G. H., Beck-Nielsen, H., Rustan, A. C., & Gaster, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-04-01
- Volume
- 54
- Issue
- 4
- Pages
- 1108-1115
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2137020115
- Cited by
- 102
- References
- 7
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Skeletal Muscle Lipid Accumulation in Type 2 Diabetes May Involve the Liver X Receptor Pathway. https://app.cochat.ai/papers/10.2337/diabetes.54.4.1108
- The paper
- Kase, E. T., Wensaas, A. J., Aas, V., Højlund, K., Levin, K., Thoresen, G. H., Beck-Nielsen, H., Rustan, A. C., & Gaster, M. (2005). Skeletal Muscle Lipid Accumulation in Type 2 Diabetes May Involve the Liver X Receptor Pathway. Diabetes. https://doi.org/10.2337/diabetes.54.4.1108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.